Previous close | 34.03 |
Open | 33.97 |
Bid | 34.01 x 100 |
Ask | 34.06 x 100 |
Day's range | 33.37 - 34.46 |
52-week range | 13.72 - 34.46 |
Volume | |
Avg. volume | 560,590 |
Market cap | 1.996B |
Beta (5Y monthly) | 2.11 |
PE ratio (TTM) | 13.39 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Comprehensive Analysis of Q1 2024 Earnings and Strategic Developments
With the business potentially at an important milestone, we thought we'd take a closer look at Protagonist...
Protagonist Therapeutics (PTGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.